STERILE AND NON-STERILE POWDER-FREE LATEX PATIENT EXAMINATION GLOVE, WITH EXTRACTABLE PROTEIN CONTENT LABELING CLAIM (50
K062917 · Wear Safe Malaysia Sdn. Bhd. · LYY · Nov 2, 2006 · General Hospital
Device Facts
Record ID
K062917
Device Name
STERILE AND NON-STERILE POWDER-FREE LATEX PATIENT EXAMINATION GLOVE, WITH EXTRACTABLE PROTEIN CONTENT LABELING CLAIM (50
Applicant
Wear Safe Malaysia Sdn. Bhd.
Product Code
LYY · General Hospital
Decision Date
Nov 2, 2006
Decision
SESE
Submission Type
Traditional
Regulation
21 CFR 880.6250
Device Class
Class 1
Intended Use
A patient examination glove is a disposable device intended for medical purposes that is worn on the examiner's hand or finger to prevent contamination between patient and examiner.
Device Story
Disposable patient examination glove; worn on examiner's hand or finger; serves as barrier to prevent cross-contamination between patient and examiner; used in clinical settings; non-sterile and sterile versions available; features extractable protein content labeling claim of 50 micrograms per gram or less.
Clinical Evidence
No clinical data provided; bench testing only.
Technological Characteristics
Material: Latex; Type: Powder-free; Protein content: 50 micrograms per gram or less; Form factor: Disposable hand/finger covering; Sterility: Available in sterile and non-sterile configurations.
Indications for Use
Indicated for use as a disposable medical device worn on the examiner's hand or finger to prevent cross-contamination between patient and examiner.
Regulatory Classification
Identification
A non-powdered patient examination glove is a disposable device intended for medical purposes that is worn on the examiner's hand or finger to prevent contamination between patient and examiner. A non-powdered patient examination glove does not incorporate powder for purposes other than manufacturing. The final finished glove includes only residual powder from manufacturing.
Related Devices
K161006 — Latex Powder Free Polymer Coated Examination Glove with Protein Labeling Claim of 50 Microgram or Less Per Gram of Glove · Hartalega Sdn Bhd · Aug 4, 2016
K031754 — FLEXISKIN POWDER FREE LATEX EXAMINATION GLOVES, NON STERILE · Pt. Mandiri Inti Buana · Jun 30, 2003
K980605 — LOW PROTEIN LATEX PATIENT EXAMINATION GLOVES (POWDER-FREE) · Pt. Sarana Indoprotex · Apr 14, 1998
K990746 — SOUTHLAND POWDERFREE LATEX EXAMINATION GLOVES WITH PROTEIN LABEL CLAIM · Southland Products Co., Ltd. · Mar 23, 1999
K972785 — CONFORM NO POWDER (PROTEIN LABELING CLAIM) EXAMINATION GLOVES · Ansell Perry · Sep 19, 1997
Submission Summary (Full Text)
{0}------------------------------------------------
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/0/Picture/1 description: The image shows the seal of the Department of Health & Human Services (HHS) of the United States. The seal features a stylized eagle with its wings spread, symbolizing protection and service. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" are arranged in a circular pattern around the eagle, indicating the department's name and national affiliation.
Public Health Service
DEC 1 9 2006
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Wear Safe Malaysia Sdn. Bhd. C/O Mr. James Logan Medical Reports Exchange 2530 Rive Road, Suite 308 Annapolis. Maryland 21401
Re: K062917
Trade/Device Name: Sterile and Non-Sterile Powder-Free Latex Patient Examination Glove, with Extractable Protein Content Labeling Claim (50 microgram per Gram of Glove or Less) Regulation Number: 880.6250 Regulation Name: Patient Examination Glove Regulatory Class: I Product Code: LYY Dated: September 26, 2006 Received: September 28, 2006
Dear Mr. Logan:
This letter corrects our substantially equivalent letter of November 2, 2006
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
{1}------------------------------------------------
## Page- 2 Mr. Logan
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to continue marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours,
Sydte y. Mchano mts.
Chiu Lin, Ph.D. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
Section 3b
## Indication for Use
K062917
510 (K) Number(If known):
Device Name:
Non-sterile Powder-free Latex Patient Examination Glove, with extractable protein content labeling claim (50 microgram per gram of glove or less)
Indication For Use:
A patient examination glove is a disposable device intended for medical purposes that is worn on the examiner's hand or finger to prevent contamination between patient and examiner.
Prescription Use (Part 21 CFR 801 Subpart D) AND / OR
Over-The-Counter Use (21 CFR 801 Subpart C)
- -
(PLEASE DO NOT WRITE BELOW THIS LINE – CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Stela M. Murphy, D 1/1/09
ി വി Anadhasiology, General New a Control, Cental Device:
K062917
{3}------------------------------------------------
510(k) Number (if known):
Device Name:
## Indications for Use
## K062917
Sterile Powder-Free Latex Patient Examination Glove, with extractable protein content labeling claim (50 microgram per gram of glove or less)
Indications For Use:
A patient examination glove is a disposable device intended for medical purposes that is worn on the examiner's hand or Finger to prevent contamination between patient and examiner
Prescription Use (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Thule M. Murphy, MD
Page 1 of 1
K62917
Panel 1
/
Sort by
Ready
Predicate graph will load when search results are available.
Embedding visualization will load when search results are available.
PDF viewer will load when search results are available.
Loading panels...
Select an item from Submissions
Click any panel, subpart, regulation, product code, or device to see details here.
Section Matches
Results will appear here.
Product Code Matches
Results will appear here.
Special Control Matches
Results will appear here.
Loading collections...
Loading
My Alerts
You will receive email notifications based on the filters and frequency you set for each alert.